DURAClone IM Granulocyte Citations
The following scientific literature references describe clinical research uses of of the listed products for immunological biomarker assessment and discovery purposes. These products are for research use only and are not labeled for diagnostic use.
Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer.
Holl EK, Frazier VN, Landa K, Beasley GM, Hwang ES, Nair SK. Front Immunol. 2019 Jul 31;10:1767. doi: 10.3389/fimmu.2019.01767. eCollection 2019.
- DURAClone IM Phenotyping Basic, Part Number B53309
- DURAClone IM B Cell, Part Number B53318
- DURAClone IM Granulocyte, Part Number B88651
- DURAClone IM T Cell Subsets, Part Number B53328
- DURAClone IM TCRs, Part Number B53340
- DURAClone IM Treg, Part Number B53346
- DURAClone IM Dendritic Cell, Part Number B53351
Immune expression in children with Wilms tumor: a pilot study
Holl EK, Routh JC, Johnston AW, Frazier V, Rice HE, Tracy ET, Nair SK. J Pediatr Urol. 2019 Mar 20. pii: S1477-5131(19)30069-5.
- DURAClone IM T Cell Subsets, Part Number B53328
- DURAClone IM B Cell, Part Number B53318
- DURAClone IM TCR, Part Number B53340
- DURAClone IM Dendritic Cell, Part Number B53351
- DURAClone IM Granulocyte, Part Number B88651
Prognostic Role of Blood NETosis in the Progression of Head and Neck Cancer
Anna Sophie Decker, Ekaterina Pylaeva, Alexandra Brenzel, Ilona Spyra, Freya Droege, Timon Hussain, Stephan Lang, Jadwiga Jablonska. Cells. 2019 Sep; 8(9): 946. Published online 2019 Aug 21.
- DURAClone IM Granulocyte, Part Number B88651